79
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia

&
Pages 203-208 | Published online: 25 Jun 2012

References

  • DworkinRHPortenoyRKPain and its persistence in herpes zosterPain1996672412518951917
  • OxmanMNLevinMJJohnsonGRA vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsNew Engl J Med20053522271228415930418
  • JohnsonRWWasnerGSaddierPBaronRPostherpetic neuralgia: epidemiology, pathophysiology and managementExpert Rev Neurother200771581159517997705
  • Pfizer Neurontin [package insert]New YorkPfizer2010
  • StewartBHKuglerARThompsonPRBockbraderHNA saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasmaPharm Res1993102762818456077
  • [No authors listed]Gabapentin extended-release – Depomed: gabapentin ER, gabapentin gastric retention, gabapentin GRDrugs R D2007831732017767396
  • WallaceMSIrvingGCowlesVEGabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre studyClin Drug Investig201030765776
  • SangCNSathyanarayanaRSweeneyMOnce-daily gabapentin (G-GR) reduces intensity of pain associated with post herpetic neuralgiaClin J Pain2012In press
  • RiceASCMatonSGroupPNSGabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled studyPain20019421522411690735
  • RowbothamMHardenNStaceyBBernsteinPMagnus-MillerLGabapentin for the treatment of postherpetic neuralgia: a randomized controlled trialJAMA1998280183718429846778
  • JohnsonPBeckerLHalpernRSweeneyTDosing patterns, therapy outcomes and health care costs among patients with postherpetic neuralgia (PHN) treated with gabapentin or pregabalinPharmacoeconomics [Submitted.]
  • CundyKCSastrySLuoWZouJMoorsTLCanafaxDMClinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentinJ Clin Pharmacol2008481378138818827074
  • BackonjaMGlanzmanRLGabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trialsClin Ther2003258110412637113
  • GordiTHouEKasichayanulaSBernerBPharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive-extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjectsClin Ther20083090991618555937
  • ChenCCowlesVEHouEPharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and foodJ Clin Pharmacol20115134635820484610
  • JohnsonRWWasnerGSaddierPBaronRHerpes zoster and postherpetic neuralgia: optimizing management in the elderly patientDrugs Aging200825991100619021299
  • BernerBCowlesVECase studies in swelling polymeric gastric retentive tabletsExpert Opin Drug Deliv2006354154816822228
  • DworkinRHCorbinAEYoungJPJrPregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trialNeurology2003601274128312707429
  • van SeventerRFeisterHAYoungJPJrStokerMVersavelMRigaudyLEfficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trialCurr Med Res Opin20062237538416466610